Ameritas Investment Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$723K Buy
1,878
+1,306
+228% +$482K 0.03% 332
2021
Q2
$293K Sell
572
-502
-47% -$89.7K 0.01% 576
2021
Q1
$141K Buy
+1,074
New +$156K 0.01% 671
2020
Q2
Sell
-550
Closed -$18K 1114
2020
Q1
$18K Buy
+550
New +$12.7K ﹤0.01% 1029

Other funds holding MRNA

Ameritas Investment Company's MRNA Position: Q3 2021 in Review

Ameritas Investment Company increased its Moderna (MRNA) stake by 228% in Q3 2021, buying an estimated $482K and bringing the position to 1,878 shares worth $723K. The position accounts for 0.03% of the portfolio, ranked #332.

Ameritas Investment Company first reported a position in MRNA in Q1 2020 and has held it in 4 quarters since. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Ameritas Investment Company held 1,878 shares of Moderna worth $723K as of Q3 2021.
  • Ameritas Investment Company bought 1,306 Moderna shares in Q3 2021, an estimated $482K.
  • Moderna made up 0.03% of Ameritas Investment Company's portfolio in Q3 2021, its #332 holding.
  • Ameritas Investment Company first reported a position in Moderna in Q1 2020 and has held it in 4 quarters since.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.